Susan Blum
Director of Finance/CFO presso MELINTA THERAPEUTICS, INC.
Profilo
Susan Blum is an Independent Director at BiomX, Inc. since 2024.
She also serves as the Chief Financial Officer at Melinta Therapeutics, Inc. since 2016.
Previously, she worked as a Controller at Textura Corp.
from 2013 to 2016.
Ms. Blum completed her undergraduate degree at Santa Clara University.
Posizioni attive di Susan Blum
| Società | Posizione | Inizio |
|---|---|---|
| MELINTA THERAPEUTICS, INC. | Director of Finance/CFO | 01/01/2016 |
| BIOMX INC. | Director/Board Member | 11/04/2024 |
Precedenti posizioni note di Susan Blum
| Società | Posizione | Fine |
|---|---|---|
| TEXTURA CORP | Comptroller/Controller/Auditor | 01/01/2016 |
Formazione di Susan Blum
| Santa Clara University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BIOMX INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Textura Corp.
 Textura Corp. Internet Software/ServicesTechnology Services Textura Corp. engages in the provision of on-demand business collaboration software to the commercial construction industry. The company was founded by William H. Eichhorn and Patrick J. Allin in September 2004 and is headquartered in Austin, TX. | Technology Services |
Melinta Therapeutics, Inc.
 Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and Minocin for injections. These antibiotics are used in the treatment of infections caused by various bacterial diseases. The company was founded by William L. Jorgensen, Peter Moore, and Thomas A. Steitz in October 2000 is headquartered in Morristown, NJ. | Health Technology |
- Borsa valori
- Insiders
- Susan Blum
